Tenet hospitals across the country are at the forefront of new treatments and are utilizing the latest technologies to provide high-quality care to our patients.
In 2017, Abrazo Arizona Heart Hospital in Phoenix began performing transcatheter aortic valve replacement (TAVR), a minimally invasive alternative to open-heart surgery, on a larger group of people after the FDA approved the procedure for patients at intermediate-risk for severe aortic stenosis.
For patients, the availability of TAVR means little to no downtime. The procedure is comparable to a balloon angioplasty treatment or an angiogram in terms of downtime and recovery, and requires a shorter hospital stay compared with traditional open-heart surgery, according to the American Heart Association.
Last summer, Abrazo Arizona Heart Hospital became one of 80 sites nationwide to perform the TAVR procedure on low-risk patients as part of a two-year advanced clinical trial. The hospital’s stepped-up involvement in research is part of a bigger plan to continue its legacy of excellence in cardiovascular care in Arizona, across the Southwest, and throughout the nation.
“This is great news for the estimated 1.5 million Americans who suffer from aortic stenosis,” said Dr. Timothy Byrne, market medical director of interventional cardiology for Abrazo Community Health Network. “We look forward to the results of the clinical trial for the lower-risk population.”
Within the Tenet family, TAVR procedures on intermediate-risk patients are now being performed at various hospitals, including Baptist Medical Center in Texas; Brookwood Baptist Medical Center and Princeton Baptist Medical Center in Alabama; Delray Medical Center and Palmetto General Hospital in Florida; Detroit Medical Center’s (DMC) Harper University Hospital in Michigan; Doctors Medical Center of Modesto in California; and Saint Vincent Hospital in Worcester, Massachusetts.
In addition to TAVR, Saint Vincent Hospital’s structural and valvular heart disease program now offers transcatheter mitral valve replacement (TMVR) through the use of the Edwards SAPIEN 3 transcatheter heart valve. This is a non-surgical approach for patients with significant mitral stenosis, which blocks the flow of blood from the left atrium to the left ventricle of the heart.
"Heart disease is the number one cause of death in the United States, killing more people every year than all forms of cancer combined,” said Jeffrey M. Welch, CEO of Saint Vincent Hospital and Tenet's Massachusetts and South Carolina hospitals. "Our goal is to bring new medical advances to our community, including transcatheter aortic valve replacement and transcatheter mitral valve repair and replacement, which could offer better outcomes for some of our most high-risk patients.”
Other Tenet hospitals performing TMVR include Brookwood Baptist Medical Center, Delray Medical Center, DMC Heart Hospital, Palm Beach Gardens Medical Center and Princeton Baptist Medical Center.